- Home
- NABL vs TLRY Comparison
NABL vs TLRY Comparison
Compare NABL & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NABL | TLRY |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | NABL | TLRY |
|---|---|---|
| Price | $6.45 | $7.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $9.45 | ★ $103.33 |
| AVG Volume (30 Days) | 968.4K | ★ 5.9M |
| Earning Date | 03-02-2026 | 01-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $497,665,000.00 | ★ $837,323,000.00 |
| Revenue This Year | $11.18 | $7.54 |
| Revenue Next Year | $8.73 | $4.89 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.65 | 0.98 |
| 52 Week Low | $6.07 | $3.51 |
| 52 Week High | $10.41 | $23.20 |
Technical Indicators
Market Signals| Indicator | NABL | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 41.69 |
| Support Level | $6.19 | $8.61 |
| Resistance Level | $6.82 | $9.31 |
| Average True Range (ATR) | 0.25 | 0.54 |
| MACD | -0.04 | -0.30 |
| Stochastic Oscillator | 20.00 | 3.47 |
Price Performance
Historical ComparisonAbout NABL N-able Inc.
N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.